Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomas.
Saved in:
| Title: | Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomas. |
|---|---|
| Authors: | Ghilardi, G.1,2,3 (AUTHOR), Chong, E.A.1,2,3 (AUTHOR), Svoboda, J.1,2,3 (AUTHOR), Wohlfarth, P.4 (AUTHOR), Nasta, S.D.1,3 (AUTHOR), Williamson, S.5 (AUTHOR), Landsburg, J.D.1,3 (AUTHOR), Gerson, J.N.1,3 (AUTHOR), Barta, S.K.1,2,3 (AUTHOR), Pajarillo, R.1,2,3 (AUTHOR), Myers, J.5 (AUTHOR), Chen, A.I.5 (AUTHOR), Schachter, L.5 (AUTHOR), Yelton, R.1,2 (AUTHOR), Ballard, H.J.1,3 (AUTHOR), Hodges Dwinal, A.5 (AUTHOR), Gier, S.2,3 (AUTHOR), Victoriano, D.2,3 (AUTHOR), Weber, E.1,3 (AUTHOR), Napier, E.1,3 (AUTHOR) |
| Source: | Annals of Oncology. Sep2022, Vol. 33 Issue 9, p916-928. 13p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 158915517 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomas. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Ghilardi%2C+G%2E%22">Ghilardi, G.</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chong%2C+E%2EA%2E%22">Chong, E.A.</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Svoboda%2C+J%2E%22">Svoboda, J.</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wohlfarth%2C+P%2E%22">Wohlfarth, P.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nasta%2C+S%2ED%2E%22">Nasta, S.D.</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Williamson%2C+S%2E%22">Williamson, S.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Landsburg%2C+J%2ED%2E%22">Landsburg, J.D.</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gerson%2C+J%2EN%2E%22">Gerson, J.N.</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Barta%2C+S%2EK%2E%22">Barta, S.K.</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pajarillo%2C+R%2E%22">Pajarillo, R.</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Myers%2C+J%2E%22">Myers, J.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+A%2EI%2E%22">Chen, A.I.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schachter%2C+L%2E%22">Schachter, L.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yelton%2C+R%2E%22">Yelton, R.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ballard%2C+H%2EJ%2E%22">Ballard, H.J.</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hodges+Dwinal%2C+A%2E%22">Hodges Dwinal, A.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gier%2C+S%2E%22">Gier, S.</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Victoriano%2C+D%2E%22">Victoriano, D.</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Weber%2C+E%2E%22">Weber, E.</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Napier%2C+E%2E%22">Napier, E.</searchLink><relatesTo>1,3</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Sep2022, Vol. 33 Issue 9, p916-928. 13p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=158915517 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2022.05.521 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 13 StartPage: 916 Titles: – TitleFull: Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomas. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ghilardi, G. – PersonEntity: Name: NameFull: Chong, E.A. – PersonEntity: Name: NameFull: Svoboda, J. – PersonEntity: Name: NameFull: Wohlfarth, P. – PersonEntity: Name: NameFull: Nasta, S.D. – PersonEntity: Name: NameFull: Williamson, S. – PersonEntity: Name: NameFull: Landsburg, J.D. – PersonEntity: Name: NameFull: Gerson, J.N. – PersonEntity: Name: NameFull: Barta, S.K. – PersonEntity: Name: NameFull: Pajarillo, R. – PersonEntity: Name: NameFull: Myers, J. – PersonEntity: Name: NameFull: Chen, A.I. – PersonEntity: Name: NameFull: Schachter, L. – PersonEntity: Name: NameFull: Yelton, R. – PersonEntity: Name: NameFull: Ballard, H.J. – PersonEntity: Name: NameFull: Hodges Dwinal, A. – PersonEntity: Name: NameFull: Gier, S. – PersonEntity: Name: NameFull: Victoriano, D. – PersonEntity: Name: NameFull: Weber, E. – PersonEntity: Name: NameFull: Napier, E. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: Sep2022 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 33 – Type: issue Value: 9 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
